Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Ovarian cancer

  • You have access
    Combination of Genistein and Cisplatin with Two Designed Monofunctional Platinum Agents in Human Ovarian Tumour Models
    LAILA ARZUMAN, PHILIP BEALE, NICK PROSCHOGO, JUN Q. YU and FAZLUL HUQ
    Anticancer Research November 2015, 35 (11) 6027-6039;
  • You have access
    Impact of Pelvic and Para-aortic Lymphadenectomy in Advanced Ovarian Cancer After Neoadjuvant Chemotherapy
    LUCIE SCHWARTZ, STEPHANIE SCHROT-SANYAN, CÉCILE BRIGAND, JEAN-JACQUES BALDAUF, ARNAUD WATTIEZ and CHERIF AKLADIOS
    Anticancer Research October 2015, 35 (10) 5503-5509;
  • You have access
    The Safety of Pegylated Liposomal Doxorubicin Plus Irinotecan in Recurrent Ovarian Cancer Patients: A Phase I Trial
    DAISUKE MIYAHARA, TAEKO UEDA, TAKAHIRO KATSUDA, MIYAKO MAEHARA, SATOSHI FUKAGAWA, KOHEI MIYATA, SUNG OUK NAM, HARUHIKO KONDO and SHINGO MIYAMOTO
    Anticancer Research August 2015, 35 (8) 4521-4525;
  • You have access
    Ataxia-Telangiectasia and RAD3-Related and Ataxia-Telangiectasia-Mutated Proteins in Epithelial Ovarian Carcinoma: Their Expression and Clinical Significance
    BANGHYUN LEE, HEE JIN LEE, HYE-YON CHO, DONG HOON SUH, KIDONG KIM, JAE HONG NO, HAERYOUNG KIM and YONG-BEOM KIM
    Anticancer Research July 2015, 35 (7) 3909-3916;
  • You have access
    Combination Efficacy of Astragalus membranaceus and Curcuma wenyujin at Different Stages of Tumor Progression in an Imageable Orthotopic Nude Mouse Model of Metastatic Human Ovarian Cancer Expressing Red Fluorescent Protein
    GANG YIN, DECAI TANG, JIANGUO DAI, MIN LIU, MIANHUA WU, YU SUN, ZHIJIAN YANG, ROBERT M. HOFFMAN, LIN LI, SHUO ZHANG and XIUXIA GUO
    Anticancer Research June 2015, 35 (6) 3193-3207;
  • You have access
    AGO Score As a Predictor of Surgical Outcome at Secondary Cytoreduction in Patients with Ovarian Cancer
    MUSTAFA ZELAL MUALLEM, KHAYAL GASIMLI, ROLF RICHTER, JUMANA ALMUHEIMID, SARA NASSER, ELENA IOANA BRAICU and JALID SEHOULI
    Anticancer Research June 2015, 35 (6) 3423-3429;
  • You have access
    A Comparative Analysis of Breast and Ovarian Cancer-related Gene Mutations in Canadian and Saudi Arabian Patients with Breast Cancer
    YUTAKA AMEMIYA, STEPHANIE BACOPULOS, MOHAMED AL-SHAWARBY, DALAL AL-TAMIMI, WALID NASER, AYESHA AHMED, MAHMOUD KHALIFA, ELZBIETA SLODKOWSKA and ARUN SETH
    Anticancer Research May 2015, 35 (5) 2601-2610;
  • You have access
    Monofunctional Platinum-containing Pyridine-based Ligand Acts Synergistically in Combination with the Phytochemicals Curcumin and Quercetin in Human Ovarian Tumour Models
    LAILA ARZUMAN, PHILIP BEALE, JUN Q. YU and FAZLUL HUQ
    Anticancer Research May 2015, 35 (5) 2783-2794;
  • You have access
    Does the Diagnosis Center Influence the Prognosis of Ovarian Cancer Patients Submitted to Neoadjuvant Chemotherapy?
    GIUSEPPE VIZZIELLI, FRANCESCO FANFANI, VITO CHIANTERA, LUCIA TORTORELLA, ALESSANDRO LUCIDI, MARCO PETRILLO, BARBARA COSTANTINI, GIOVANNI SCAMBIA and ANNA FAGOTTI
    Anticancer Research May 2015, 35 (5) 3027-3032;
  • You have access
    Low-dose Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) as an Alternative Therapy for Ovarian Cancer in an Octogenarian Patient
    URS GIGER-PABST, WIEBKE SOLASS, BERND BUERKLE, MARC-ANDRÉ REYMOND and CLEMENS B. TEMPFER
    Anticancer Research April 2015, 35 (4) 2309-2314;

Pages

  • Previous
  • Next
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • …
  • 20
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire